Could a simple drink replace feeding tubes for head and neck cancer patients?
NCT ID NCT07242365
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase II trial tests whether Soylent, a liquid meal replacement, can help head and neck cancer patients avoid needing a feeding tube during chemoradiotherapy. About 60 patients with locally advanced cancer will drink Soylent alongside their treatment. The goal is to see if this reduces malnutrition and the need for gastrostomy tube placement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Soylent liquid meal replacement
- What this could lead to
- If it works, this could offer a simple nutritional drink to help patients avoid feeding tubes during cancer treatment.
- What could go wrong
- This is a small, early-phase study with only 60 participants, so results may not apply to everyone. The drink may not be enough to prevent malnutrition or tube placement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED HEAD AND NECK CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.